Tag: <span>Solid organ transplant</span>

Tag: Solid organ transplant

“Udonitrectag” receives orphan drug designation from the European Commission as treatment in solid organ transplantation

On 15/11/2021, orphan designation (EU/3/21/2521) was granted by the European Commission to MIMETECH S.r.l., Italy, for Udonitrectag as treatment in solid organ transplantation. When organs are transplanted, the period in which they are cut off from their normal blood supply can lead to damage and death of cells that means …

Solid organ transplant

Solid organs destined to transplantation undergo ischemic damage as soon as they are explanted and then during their storage period. An additional injure, due to reperfusion, supervenes at the moment of their re-implant in the recipient. This medical field is, therefore, one of the most representative conditions of the Ischemia/Reperfusion (I/R) damage, …